price
IP
NASDAQ · IPHA
Innate Pharma S.A.
Healthcare · Biotechnology
$1.86
Up+$0.01 (+0.54%)
Updated Sep 16, 2026, 11:58 AM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 159.21M
- P/E ratio
- -3.1
- Dividend yield
- 0.00%
- 52-week range
- $1.17 – $2.71
- Volume
- 47.79K
- Avg. volume
- 194.86K
Price performance
IPHA price history
1M range · 20 trading sessions · Daily adjusted prices
IPHA closed at $1.86 after 20 trading sessions, down 10.14% for the selected period.
- Last close
- $1.86
- Period change
- -10.14%
- Period low
- $1.85
- Period high
- $2.27
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $1.85 | $1.92 | $1.84 | $1.86 | 47.79K |
| Sep 14, 2026 | $1.86 | $1.90 | $1.813 | $1.85 | 20.79K |
| Sep 11, 2026 | $1.89 | $1.93 | $1.87 | $1.87 | 8.32K |
| Sep 10, 2026 | $1.91 | $1.94 | $1.88 | $1.88 | 8.47K |
| Sep 9, 2026 | $2.01 | $2.04 | $1.95 | $1.95 | 24.04K |
| Sep 8, 2026 | $2.04 | $2.06 | $2.00 | $2.05 | 27.54K |
| Sep 4, 2026 | $2.10 | $2.15 | $2.0258 | $2.08 | 8.98K |
| Sep 3, 2026 | $2.14 | $2.20 | $2.09 | $2.11 | 10.89K |
| Sep 2, 2026 | $2.23 | $2.23 | $2.12 | $2.17 | 17.4K |
| Sep 1, 2026 | $2.1401 | $2.1401 | $2.11 | $2.12 | 16.66K |
| Aug 31, 2026 | $2.21 | $2.2899 | $2.17 | $2.17 | 9.96K |
| Aug 28, 2026 | $2.26 | $2.2895 | $2.22 | $2.22 | 11.8K |
| Aug 27, 2026 | $2.22 | $2.26 | $2.22 | $2.23 | 6.06K |
| Aug 26, 2026 | $2.22 | $2.25 | $2.16 | $2.16 | 20.47K |
| Aug 25, 2026 | $2.2201 | $2.28 | $2.21 | $2.27 | 27.97K |
| Aug 24, 2026 | $2.21 | $2.28 | $2.18 | $2.205 | 58.94K |
| Aug 21, 2026 | $2.24 | $2.30 | $2.20 | $2.26 | 44.36K |
| Aug 20, 2026 | $2.14 | $2.16 | $2.05 | $2.09 | 52.55K |
| Aug 19, 2026 | $2.11 | $2.13 | $2.09 | $2.12 | 27.07K |
| Aug 18, 2026 | $2.13 | $2.13 | $2.04 | $2.07 | 46.49K |
Latest IPHA news
The latest Smart Investors Daily articles mentioning IPHA.
Stock researchMarket Activity · Institutional Ownership
Loading stock research…